US 9592238
Anti-ceramide monoclonal antibody 2A2
granted A61KA61K2039/505A61K31/55
Quick answer
US patent 9592238 (Anti-ceramide monoclonal antibody 2A2) held by The Board of Regents of the University of Texas System expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K31/55, A61P, A61P1/00